Genentech’s Ocrelizumab First Investigational Medicine to Show Efficacy in People with Primary Progressive Multiple Sclerosis in Large Phase III Study.
Click here to read
Genentech’s Ocrelizumab First Investigational Medicine to Show Efficacy in People with Primary Progressive Multiple Sclerosis in Large Phase III Study.
Click here to read
Comments are closed.
This is so exciting! It bodes well for so many ms-ers. And gives hope for us SPMS people that something will arrive for us. I know it won't be "on the shelf" any time too soon, but I hope when it does, that it works well for you.